摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-3-(3-methoxyphenoxy)pyrrolidine | 931409-73-3

中文名称
——
中文别名
——
英文名称
(S)-3-(3-methoxyphenoxy)pyrrolidine
英文别名
(3S)-3-(3-methoxyphenoxy)pyrrolidine;Pyrrolidine, 3-(3-methoxyphenoxy)-, (3S)-
(S)-3-(3-methoxyphenoxy)pyrrolidine化学式
CAS
931409-73-3
化学式
C11H15NO2
mdl
MFCD08688087
分子量
193.246
InChiKey
XEJBWNVKUCYHJV-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    307.4±32.0 °C(Predicted)
  • 密度:
    1.084±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    30.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (S)-3-(3-methoxyphenoxy)pyrrolidine4-cyano-4,4-diphenylbutanoic acid1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 18.0h, 以100%的产率得到5-oxo-5-[(3S)-3-phenoxypyrrolidin-1-yl]-2,2-diphenylpentanenitrile
    参考文献:
    名称:
    Inhalation by Design: Novel Tertiary Amine Muscarinic M3 Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease
    摘要:
    A novel tertiary amine series of potent muscarinic M-3 receptor antagonists are described that exhibit potential as inhaled long-acting bronchodilators for the treatment of chronic obstructive pulmonary disease. Geminal dimethyl functionality present in this series of compounds confers very long dissociative half-life (slow off-rate) from the M-3 receptor that mediates very long-lasting smooth muscle relaxation in guinea pig tracheal strips. Optimization of pharmacokinetic properties was achieved by combining rapid oxidative clearance with targeted introduction of a phenolic moiety to secure rapid glucuronidation. Together, these attributes minimize systemic exposure following inhalation, mitigate potential drug-drug interactions, and reduce systemically mediated adverse events. Compound 47 (PP-3635659) is identified as a Phase II clinical candidate from this series with in vivo duration of action studies confirming its potential for once-daily use in humans.
    DOI:
    10.1021/jm200884j
  • 作为产物:
    描述:
    tert-butyl (3S)-3-(3-methoxyphenoxy)pyrrolidine-1-carboxylate 在 盐酸 作用下, 以 1,4-二氧六环甲醇 为溶剂, 反应 3.0h, 以85%的产率得到(S)-3-(3-methoxyphenoxy)pyrrolidine
    参考文献:
    名称:
    WO2007/34325
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Carboxamide derivatives as muscarinic receptor antagonists
    申请人:Glossop Alan Paul
    公开号:US20070105831A1
    公开(公告)日:2007-05-10
    The invention relates to compounds of formula processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
    本发明涉及具有下列公式的化合物、其制备方法和中间体,以及包含它们的抗胆碱能药物组合物。
  • Carboxamide Derivatives As Muscarinic Receptor Antagonists
    申请人:Glossop Paul Alan
    公开号:US20100029720A1
    公开(公告)日:2010-02-04
    The invention relates to compounds of formula processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
    本发明涉及具有以下式的化合物,以及制备它们的过程和中间体,它们作为毒蕈碱受体拮抗剂的用途和包含它们的制药组合物。
  • CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
    申请人:Pfizer Limited
    公开号:EP1928821B1
    公开(公告)日:2009-01-07
  • US7772223B2
    申请人:——
    公开号:US7772223B2
    公开(公告)日:2010-08-10
  • US8268881B2
    申请人:——
    公开号:US8268881B2
    公开(公告)日:2012-09-18
查看更多